Aug 222017 CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies Collaboration expands CRISPR Therapeutics’ efforts in immuno-oncology.
